Radiotherapy in glioblastoma: 8 expert insights

Radiotherapy

Glioblastoma is one of the most aggressive brain tumors, accounting for nearly 47% of malignant brain tumors according to recent studies. Radiotherapy has been proven to extend survival significantly, making it a cornerstone of care. In this article, Dr. Mathangi J, Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute in Bangalore, shares eight critical insights that redefine excellence in radiotherapy in glioblastoma.

1. What is radiotherapy in glioblastoma and why is it essential?

Radiotherapy in glioblastoma is the targeted use of high-energy radiation beams to destroy rapidly dividing cancer cells in the brain. Under the expertise of Dr. Mathangi, advanced systems like TrueBeam STx and Stereotactic techniques ensure precision while sparing healthy tissues. By carefully planning treatment, patients gain improved tumor control and quality of life. Without radiotherapy, recurrence rates soar, leaving patients with limited options.

2. Brain tumor radiation approach for complex cases

The brain tumor radiation approach must be individualized. Dr. Mathangi uses image-guided RapidArc therapy and SRS/SBRT techniques learned from Frankfurt and Copenhagen to optimize dose delivery. This approach minimizes damage to healthy neurons while focusing the highest energy where it’s needed most. Her protocols integrate imaging, simulation, and adaptive planning to adjust therapy as tumors shrink or shift during treatment.

3. Oncology treatment glioblastoma using modern technology

When discussing oncology treatment glioblastoma, technology plays a pivotal role. Dr. Mathangi has overseen the installation of Asia Pacific’s first TrueBeam STx machine at Gleneagles, offering unmatched precision and speed. Combined with her experience in intraoperative radiotherapy, patients benefit from multimodal treatment plans—surgery, chemotherapy, and radiotherapy seamlessly coordinated for maximal effectiveness.

4. Radiotherapy guidelines followed by global leaders

Following stringent radiotherapy guidelines is non-negotiable in delivering safe and effective care. Dr. Mathangi applies protocols recommended by the National Comprehensive Cancer Network (NCCN) and European Society for Radiotherapy & Oncology (ESTRO). These guidelines inform dose limits, margins, and schedules, ensuring consistency and reducing adverse effects. Her adherence to evidence-based practices provides patients with world-class cancer care right in Bangalore.

5. Tumor dose planning for precision and safety

Effective tumor dose planning determines the success of radiotherapy. Dr. Mathangi’s team uses advanced planning software and 3D conformal mapping to calculate the optimal dose while preserving neurological function. By performing gated RapidArc and DIBH-gated radiotherapy, she accounts for even subtle brain movements caused by breathing or positioning, minimizing collateral damage.

6. Patient care in brain cancer beyond treatment

Comprehensive patient care in brain cancer extends beyond radiation delivery. Dr. Mathangi emphasizes nutritional guidance, psychological support, and physiotherapy to improve resilience and recovery. Her holistic approach includes regular follow-ups, side-effect management, and family counseling—critical factors that empower patients and caregivers during a challenging journey.

7. Radiation oncology for glioblastoma tailored to each patient

The complexity of radiation oncology for glioblastoma demands individualized treatment. Dr. Mathangi customizes beam arrangements, dose intensities, and schedules to each patient’s tumor profile and overall health. She collaborates with neurosurgeons and medical oncologists to integrate radiotherapy into a multimodal plan, improving local control and prolonging survival.

8. Glioblastoma survival care and long-term outcomes

Survival after glioblastoma is a multifaceted challenge. Glioblastoma survival care under Dr. Mathangi’s leadership includes vigilant monitoring for recurrence, early detection of new lesions, and supportive therapies that maintain cognitive function. Her dedication to advanced radiotherapy and compassionate care offers patients hope and a better quality of life.

How Dr. Mathangi ensures excellence in cancer care

  • Over 20 years of expertise treating head and neck cancers, brain tumors, spine tumors, lung, liver, breast, bladder, prostate, uterine, cervical, vulval, anal canal, esophagus, and rectal cancers.
  • Director of Fellowship in Advanced Radiotherapy Techniques affiliated with RGUHS, mentoring the next generation of oncologists.
  • Training from leading institutions in Germany and Denmark, ensuring world-class care in India.
  • Over 12,000 successfully treated patients with cutting-edge technologies.

Why choosing Dr. Mathangi at Gleneagles Cancer Institute matters

Gleneagles Cancer Institute in Bangalore is renowned for advanced cancer treatments. Missing the opportunity to be treated here under Dr. Mathangi could mean missing access to cutting-edge technologies and personalized strategies. Her ability to blend compassion with innovation ensures patients feel supported, not just treated. To book an appointment, visit this form and submit your contact information—her team will schedule your consultation promptly.

About Dr. Mathangi

Dr. Mathangi J is a highly respected radiation oncologist based in Bangalore, India. She serves as the Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute. Specializing in complex cancers, including glioblastoma, she combines advanced training, research-backed protocols, and compassionate patient care. Her profile reflects leadership in radiotherapy innovation across South and North India.

Radiotherapy in glioblastoma: Frequently asked questions

Below are clear, concise answers from Dr. Mathangi J, Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. Tap a question to expand. For visits and consults, request an appointment.

Radiotherapy in glioblastoma aims to destroy residual tumor cells after surgery or biopsy and to delay progression when surgery is not feasible. Under Dr. Mathangi’s care, treatment typically begins 2–6 weeks after surgery, once healing is adequate, MRI mapping is complete, and performance status is optimized.

Next step: Book a consult to map a personalized timeline.

The brain tumor radiation approach is tailored using MRI/CT fusion, target contouring, and immobilization masks to keep your head still. With techniques such as RapidArc, image guidance, and stereotactic boosts, Dr. Mathangi shapes beams to the tumor while protecting eloquent brain areas involved in speech, memory, and motor function.

A comprehensive oncology treatment glioblastoma plan typically combines maximal safe surgery, radiotherapy, and concurrent/adjuvant temozolomide. Depending on molecular markers and performance status, Dr. Mathangi may add tumor treating fields or consider stereotactic re-irradiation at recurrence within multidisciplinary review.

She adheres to internationally recognized radiotherapy guidelines (e.g., contouring atlases and dose-constraint frameworks) to standardize planning and minimize toxicity. These protocols govern margins, dose per fraction, organ-at-risk limits, and imaging frequency, ensuring reproducible, evidence-led care.

In tumor dose planning, Dr. Mathangi uses inverse planning and dose-volume histogram checks to ensure targets get adequate coverage while critical organs (optic pathways, brainstem, hippocampi) stay within limits. Adaptive strategies can refine the plan if swelling subsides or cavities contract during the treatment course.

Holistic patient care in brain cancer includes anti-edema strategies, anti-seizure medications when indicated, neurocognitive monitoring, nutrition, and fatigue management. The team provides counseling for caregivers, return-to-work guidance where feasible, and rehabilitation referrals to preserve independence and quality of life.

Radiation oncology for glioblastoma may employ stereotactic radiosurgery or hypofractionation for small residual disease, well-demarcated recurrences, or in patients needing shorter courses. With TrueBeam STx precision and image guidance, Dr. Mathangi can intensify dose to focal targets while keeping normal tissue exposures low.

Glioblastoma survival care centers on MRI surveillance (initially every 2–3 months), symptom tracking, steroid tapering when safe, neuro-rehab, and early evaluation of suspected progression. At recurrence, options include re-irradiation, systemic therapy adjustments, trials (when eligible), and supportive measures to maintain cognition and function.

Precision planning, daily image guidance, and careful fractionation limit acute effects like fatigue or scalp irritation. Long-term risk to memory or vision is mitigated by respecting dose constraints and using hippocampal-sparing approaches where appropriate. Education on sleep, hydration, and light activity further improves tolerance.

After simulation and planning (usually 5–10 business days), sessions last about 10–20 minutes. You’ll lie on a treatment couch wearing a custom mask; the machine moves around you but does not touch you. Most patients resume routine activities the same day, with weekly reviews by Dr. Mathangi’s team.

Ready to begin? Send your details and the care team will schedule you.

Alongside glioblastoma, Dr. Mathangi routinely manages head and neck cancers, spine tumors, esophagus and rectal cancers, lung cancers, liver cancers, breast cancers, bladder cancers, prostate cancers, uterine cancers, cervical cancer, vulval cancers, anal canal cancers, and penile cancers—coordinating care with neurosurgery and medical oncology.

Her leadership, fellowship training program, and access to platforms like TrueBeam STx ensure meticulous planning and delivery. Patients benefit from swift imaging-to-treatment workflows, strong supportive care, and rapid escalation paths if disease behavior changes.

By using this website - You confirm to have read and agree to the Disclaimer statement, Privacy Policy and the Terms & Conditions of this website.
Chat

Speak Directly With a
Trusted Radiation Oncology Expert




Your information is kept strictly confidential.

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram